"oncology" Post in this tag
alkylating agents

adverse effects

pharmacology hematology oncology   HirotoShishido

tumor lysis syndrome
oncology hematology UWorld   HirotoShishido

PD-1, PD-L1 antibody
immunology UWorld oncology   HirotoShishido

chemotherapy induced cerebellar degeneration
drugs

pharmacology oncology   HirotoShishido

platinum agent
medications, clinical use, adverse effects

pharmacology oncology UWorld SIM1   HirotoShishido

neuroendocrine markers for SCLC(small cell lung cancer)
respiratory oncology UWorld   HirotoShishido

What neoplasms are associated with psammoma bodies?
pathology oncology   HirotoShishido

lung adenocarcinoma
histology, mutation

respiratory oncology Amboss level4   HirotoShishido

antimetabolites
microtubule inhibiters
platinum agents
alkylating agents
topoisomerase inhibitors
bleomycin

cell cycle

oncology pharmacology biochemistry   HirotoShishido

therapeutic antibodies whose target is CTLA-4, drug, clinical use, mechanism
immunology pharmacology oncology   HirotoShishido

what is assoiated with
dietary nitrosamines, arsenic, contraceptive pills, polyvinyl chloride

oncology gastrointestinal UWorld   HirotoShishido

targeted drug therapy
oncology pharmacology UWorld   HirotoShishido

Sister Mary Joseph nodule
Blumer shelf

oncology gastrointestinal   HirotoShishido

BRAF neoplasm
pathology oncology UWorld   HirotoShishido

喀痰細胞診の対象者
必修 respiratory oncology   HirotoShishido

anticancer drugs whose adverse effects may manifest as endometrial cancer
reproductive oncology UWorld step2CK   HirotoShishido